HU Hong-Ming, 胡红明

Hu Hong-Ming, PhD

  • Immuxell, Founder, Chairman, and CSO
    Shanghai China

Education Ph.D. in Tumor Immunology, Oregon Health and Science University, Port-land, Oregon, 2002.

M.S. in Molecular Biology, Shanghai Institute of Biochemistry,
Chinese Academy of Science, Shanghai, China, 1990.

B.S. in Biochemistry, School of Life Science,
Fudan University, Shanghai, China, 1987.

Professional Experience
Employment
Lab Chief, Laboratory of Cancer Immunobiology,
Earle A. Chiles Research Institute, Providence Medical Center, Portland, Oregon. 2003-2020.

Senior Research Associate, Laboratory of Dr. Bernard A. Fox
Earle A. Chiles Research Institute, Providence Medical Center,
Portland, Oregon. 1994-2003.

Research Associate, Laboratory of Dr. Vishva M. Dixit,
Department of Pathology, University of Michigan Medical School,
Ann Arbor, Michigan. 1991-1994.

Affiliations
ImmuXell, Founder, Chairman, and CSO 2021-
UbiVAC, CSO 2010-

Clinical adjunct professor, Department of Radiation Oncology,
Oregon Health and Science University (OHSU), Portland, Oregon.
2006-2013.

Adjunct Professor, Department of Physics,
Portland State University, Portland, Oregon. 2009-2014.

Guest Professor, School of Medicine, Xian Jiaotong University 2004-2008
Guest Professor, Shanghai Jiaotong University 2018 to 2020

Honor and Awards

American Cancer Society Research Scholar (2003-2007)